MedTrace Logo

SuperNO2VA™ and General Anesthesia Postoperative Care

NCT03969615 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-06-03

No results posted yet for this study

Summary

The purpose of the study is to randomly and prospectively evaluate the differences in outcomes between the control group (closed full facemask immediate post-extubation with standard oxygenating device used post-operatively in PACU) and the SuperNO2VA™ group (SuperNO2VA™ immediate post-extubation and post-operatively in PACU)

Conditions

  • Hypoxemia
  • Acute Respiratory Failure

Interventions

DEVICE

SuperNO2VA nasal positive airway pressure devic

SuperNO2VA nasal positive airway pressure device utilizes supplemental oxygen and an adjustable pressure limiting valve to maintain upper airway latency

DEVICE

Supplemental oxygen

5lpm of supplemental oxygen

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Vyaire Medical

    lead INDUSTRY

Principal Investigators

  • Carin Hagberg, MD · The University of Texas MD Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-15
Primary Completion
2019-10-15
Completion
2019-10-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03969615 on ClinicalTrials.gov